GeneDx Holdings Corp. Inventory Write-down
GeneDx Holdings Corp. (WGS) reported Inventory Write-down of $135.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-02-23
- GeneDx Holdings Corp. inventory write-down for the quarter ending 2025-12-31 was -$17.00K, a 139.53% decline year-over-year.
- GeneDx Holdings Corp. inventory write-down for the quarter ending 2025-09-30 was $29.00K, a 3.57% increase year-over-year.
- GeneDx Holdings Corp. inventory write-down for the quarter ending 2024-12-31 was $43.00K, a 84.59% decline year-over-year.
- GeneDx Holdings Corp. inventory write-down for the quarter ending 2024-09-30 was $28.00K, a 97.24% decline year-over-year.
- GeneDx Holdings Corp. inventory write-down for fiscal 2025 was $135.00K, a 25.00% decline from fiscal 2024.
- GeneDx Holdings Corp. inventory write-down for fiscal 2024 was $180.00K, a 95.40% decline from fiscal 2023.
- GeneDx Holdings Corp. inventory write-down for fiscal 2023 was $3.91M, a 247.82% increase from fiscal 2022.
- GeneDx Holdings Corp. inventory write-down for fiscal 2022 was $1.13M, a 47.16% decline from fiscal 2021.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $12.00K derived: sum of 2 quarters · filed 2026-02-23 | $135.00K 10-K · filed 2026-02-23 | |
| 2025-09-30 | $29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $152.00K 10-Q · filed 2025-10-28 | ||
| 2025-06-30 | $123.00K 10-Q · filed 2025-07-29 | |||
| 2024-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $71.00K derived: sum of 2 quarters · filed 2026-02-23 | $140.00K derived: sum of 3 quarters · filed 2026-02-23 | $180.00K 10-K · filed 2026-02-23 |
| 2024-09-30 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $97.00K derived: sum of 2 quarters · filed 2025-10-28 | $137.00K 10-Q · filed 2025-10-28 | $416.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $69.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $109.00K 10-Q · filed 2025-07-29 | $388.00K derived: sum of 3 quarters · filed 2026-02-23 | $1.40M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $40.00K 10-Q · filed 2024-04-29 | $319.00K derived: sum of 2 quarters · filed 2026-02-23 | $1.33M derived: sum of 3 quarters · filed 2026-02-23 | $3.95M derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $279.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $1.29M derived: sum of 2 quarters · filed 2026-02-23 | $3.91M derived: sum of 3 quarters · filed 2026-02-23 | $3.91M 10-K · filed 2026-02-23 |
| 2023-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $3.63M derived: sum of 2 quarters · filed 2024-10-29 | $3.63M 10-Q · filed 2024-10-29 | $4.03M derived: sum of 4 quarters · filed 2024-10-29 |
| 2023-06-30 | $2.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $2.62M 10-Q · filed 2024-07-30 | $3.01M derived: sum of 3 quarters · filed 2024-07-30 | $3.40M derived: sum of 4 quarters · filed 2024-07-30 |
| 2023-03-31 | $0.00 10-Q · filed 2024-04-29 | $393.00K derived: sum of 2 quarters · filed 2024-04-29 | $778.00K derived: sum of 3 quarters · filed 2024-04-29 | $1.08M derived: sum of 4 quarters · filed 2024-04-29 |
| 2022-12-31 | $393.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $778.00K derived: sum of 2 quarters · filed 2024-02-23 | $1.08M derived: sum of 3 quarters · filed 2024-02-23 | $1.13M 10-K · filed 2024-02-23 |
| 2022-09-30 | $385.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $689.00K derived: sum of 2 quarters · filed 2023-11-03 | $732.00K 10-Q · filed 2023-11-03 | $1.74M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $304.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $347.00K 10-Q · filed 2023-08-08 | $1.35M derived: sum of 3 quarters · filed 2023-08-08 | $10.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $43.00K 10-Q · filed 2023-05-09 | $1.05M derived: sum of 2 quarters · filed 2023-05-09 | -$294.00K derived: sum of 3 quarters · filed 2023-05-09 | $351.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$337.00K derived: sum of 2 quarters · filed 2023-03-16 | $308.00K derived: sum of 3 quarters · filed 2023-03-16 | $2.13M 10-K · filed 2023-03-16 |
| 2021-09-30 | -$1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$699.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.12M 10-Q · filed 2022-11-14 | $1.12M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $645.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $2.47M 10-Q · filed 2022-08-15 | $2.47M derived: sum of 3 quarters · filed 2023-03-16 | |
| 2021-03-31 | $1.82M 10-Q · filed 2022-05-12 | $1.82M derived: sum of 2 quarters · filed 2023-03-16 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 10-K · filed 2023-03-16 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |